- Exercise self-efficacy at baseline [ Time Frame: At baseline ]
Exercise self-efficacy will be measured via the Chinese version of Self-Efficacy for Exercise (SEE-C). The total score ranges from 0 to 90. The higher the score, the greater the exercise self-efficacy.
- Exercise self-efficacy at Week 12 [ Time Frame: At Week 12 ]
Exercise self-efficacy will be measured via the Chinese version of Self-Efficacy for Exercise (SEE-C). The total score ranges from 0 to 90. The higher the score, the greater the exercise self-efficacy.
- Exercise self-efficacy at Week 24 [ Time Frame: At Week 24 ]
Exercise self-efficacy will be measured via the Chinese version of Self-Efficacy for Exercise (SEE-C). The total score ranges from 0 to 90. The higher the score, the greater the exercise self-efficacy.
- Exercise self-efficacy at Week 36 [ Time Frame: At Week 36 ]
Exercise self-efficacy will be measured via the Chinese version of Self-Efficacy for Exercise (SEE-C). The total score ranges from 0 to 90. The higher the score, the greater the exercise self-efficacy.
- ASCVD risk profiles (Blood pressure, weight, height, BMI & waist circumference, heart rate) at baseline [ Time Frame: At baseline ]
The ASCVD risk profiles will be assessed by physical evaluations carried out by blinded, trained outcome assessors.
- ASCVD risk profiles (Blood pressure, weight, height, BMI & waist circumference, heart rate) at Week 12 [ Time Frame: At Week 12 ]
The ASCVD risk profiles will be assessed by physical evaluations carried out by blinded, trained outcome assessors.
- ASCVD risk profiles (Blood pressure, weight, height, BMI & waist circumference, heart rate) at Week 24 [ Time Frame: At Week 24 ]
The ASCVD risk profiles will be assessed by physical evaluations carried out by blinded, trained outcome assessors.
- ASCVD risk profiles (Blood pressure, weight, height, BMI & waist circumference, heart rate) at Week 36 [ Time Frame: At Week 36 ]
The ASCVD risk profiles will be assessed by physical evaluations carried out by blinded, trained outcome assessors.
- ASCVD risk profiles (Fasting blood glucose and fasting blood lipids including low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides) at baseline [ Time Frame: At baseline ]
The ASCVD risk profiles will be assessed by obtaining finger-prick blood samples using an auto-analyser, carried out by blinded, trained outcome assessors. Fasting 8 hours before obtaining blood samples will be required.
- ASCVD risk profiles (Fasting blood glucose and fasting blood lipids including low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides) at Week 24 [ Time Frame: At Week 24 ]
The ASCVD risk profiles will be assessed by obtaining finger-prick blood samples using an auto-analyser, carried out by blinded, trained outcome assessors. Fasting 8 hours before obtaining blood samples will be required.
- ASCVD risk profiles (Fasting blood glucose and fasting blood lipids including low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides) at Week 36 [ Time Frame: At Week 36 ]
The ASCVD risk profiles will be assessed by obtaining finger-prick blood samples using an auto-analyser, carried out by blinded, trained outcome assessors. Fasting 8 hours before obtaining blood samples will be required.
- ASCVD risk profiles (2-minute walk test) at baseline [ Time Frame: At baseline ]
2-minute walk test will be adopted to examine aerobic capacity and self-paced walking capacity by measuring the walking distance covered at two minutes. It will be assessed by blinded, trained outcome assessors.
- ASCVD risk profiles (2-minute walk test) at Week 12 [ Time Frame: At Week 12 ]
2-minute walk test will be adopted to examine aerobic capacity and self-paced walking capacity by measuring the walking distance covered at two minutes. It will be assessed by blinded, trained outcome assessors.
- ASCVD risk profiles (2-minute walk test) at Week 24 [ Time Frame: At Week 24 ]
2-minute walk test will be adopted to examine aerobic capacity and self-paced walking capacity by measuring the walking distance covered at two minutes. It will be assessed by blinded, trained outcome assessors.
- ASCVD risk profiles (2-minute walk test) at Week 36 [ Time Frame: At Week 36 ]
2-minute walk test will be adopted to examine aerobic capacity and self-paced walking capacity by measuring the walking distance covered at two minutes. It will be assessed by blinded, trained outcome assessors.
- Adverse events throughout the program [ Time Frame: Throughout the study period ]
Unfavorable or unintended events regarding the programme reported by participants throughout the study period.
- Eligibility rate [ Time Frame: At baseline ]
The number of eligible potential participants divided by the number of screened people
- Recruitment rate [ Time Frame: At baseline ]
The percentage of participants who consent to join the study and being recruited
- Retention rate at baseline [ Time Frame: At baseline ]
The percentage of participants remaining in the study
- Retention rate at Week 12 [ Time Frame: At Week 12 ]
The percentage of participants remaining in the study
- Retention rate at Week 24 [ Time Frame: At Week 24 ]
The percentage of participants remaining in the study
- Retention rate at Week 36 [ Time Frame: At Week 36 ]
The percentage of participants remaining in the study
- Lecture attendance rate [ Time Frame: Immediately after education session ]
The number of participants in the control group who attend the education talk divided by the number of participants who are randomized into the control group The number of participants in the experimental group who attend the education session divided by the number of participants who are randomized into the experimental group The number of participants in the two groups who attend the education session divided by the number of randomized participants
- Adherence to intervention [ Time Frame: At Week 36 ]
The number of participants in the experimental group who practice the tailor-made exercise learned during the intervention divided by the number of participants in the experimental group Experimental group's frequency in performing tailor-made exercise related to the recommended exercise dosage
- Attendance rate to data collection at baseline [ Time Frame: At baseline ]
The number of participants in the control group who attend the data collection divided by the number of participants who are randomized into the control group The number of participants in the experimental group who attend the data collection divided by the number of participants who are randomized into the experimental group The number of participants who attend the data collection divided by the number of randomized participants
- Attendance rate to data collection at Week 12 [ Time Frame: At Week 12 ]
The number of participants in the control group who attend the data collection divided by the number of participants who are randomized into the control group The number of participants in the experimental group who attend the data collection divided by the number of participants who are randomized into the experimental group The number of participants who attend the data collection divided by the number of randomized participants
- Attendance rate to data collection at Week 24 [ Time Frame: At Week 24 ]
The number of participants in the control group who attend the data collection divided by the number of participants who are randomized into the control group The number of participants in the experimental group who attend the data collection divided by the number of participants who are randomized into the experimental group The number of participants who attend the data collection divided by the number of randomized participants
- Attendance rate to data collection at Week 36 [ Time Frame: At Week 36 ]
The number of participants in the control group who attend the data collection divided by the number of participants who are randomized into the control group The number of participants in the experimental group who attend the data collection divided by the number of participants who are randomized into the experimental group The number of participants who attend the data collection divided by the number of randomized participants
- Questionnaire completion rate at baseline [ Time Frame: At baseline ]
The number of participants who complete the questionnaire divided by the number of distributed questionnaires
- Questionnaire completion rate at Week 12 [ Time Frame: At Week 12 ]
The number of participants who complete the questionnaire divided by the number of distributed questionnaires
- Questionnaire completion rate at Week 24 [ Time Frame: At Week 24 ]
The number of participants who complete the questionnaire divided by the number of distributed questionnaires
- Questionnaire completion rate at Week 36 [ Time Frame: At Week 36 ]
The number of participants who complete the questionnaire divided by the number of distributed questionnaires
- Missing data at baseline [ Time Frame: At baseline ]
The percentage of missing data
- Missing data at Week 12 [ Time Frame: At Week 12 ]
The percentage of missing data
- Missing data at Week 24 [ Time Frame: At Week 24 ]
The percentage of missing data
- Missing data at Week 36 [ Time Frame: At Week 36 ]
The percentage of missing data
- Structured questionnaire [ Time Frame: At baseline ]
The questionnaire will primarily include patient demographics, medical history, lifestyle patterns, medication use and physical fitness evaluation data, etc.
- Physical activity level (total score) at baseline [ Time Frame: At baseline ]
The physical activity level will be measured by the Chinese Version of Physical Activity Scale for the Elderly (PASE-C). The total score (from zero to 400 or above) is quantified based on frequency values and weights for these activities. The higher the score, the higher the level of physical activity.
- Physical activity level (total score) at Week 12 [ Time Frame: At Week 12 ]
The physical activity level will be measured by the Chinese Version of Physical Activity Scale for the Elderly (PASE-C). The total score (from zero to 400 or above) is quantified based on frequency values and weights for these activities. The higher the score, the higher the level of physical activity.
- Physical activity level (total score) at Week 36 [ Time Frame: At Week 36 ]
The physical activity level will be measured by the Chinese Version of Physical Activity Scale for the Elderly (PASE-C). The total score (from zero to 400 or above) is quantified based on frequency values and weights for these activities. The higher the score, the higher the level of physical activity.
- Physical activity level (classification of physical activity level) at baseline [ Time Frame: At baseline ]
The physical activity level will be measured by the Chinese version of International Physical Activity Questionnaire-short form (IPAQ-C-short form). Participants are classified into "inactive", "minimally active" or "health enhancing physical activity (HEPA) active" based on their physical activity levels.
- Physical activity level (classification of physical activity level) at Week 12 [ Time Frame: At Week 12 ]
The physical activity level will be measured by the Chinese version of International Physical Activity Questionnaire-short form (IPAQ-C-short form). Participants are classified into "inactive", "minimally active" or "health enhancing physical activity (HEPA) active" based on their physical activity levels.
- Physical activity level (classification of physical activity level) at Week 36 [ Time Frame: At Week 36 ]
The physical activity level will be measured by the Chinese version of International Physical Activity Questionnaire-short form (IPAQ-C-short form). Participants are classified into "inactive", "minimally active" or "health enhancing physical activity (HEPA) active" based on their physical activity levels.
